Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:
Announcement on Convening the 2024 Annual and Q1 2025 Performance Briefing
Filed with SSE · · 2 pages · Chinese
Release
Autobio Diagnostics Co., Ltd. on 6ix
Earlier from Autobio Diagnostics
- Announcement on Resolution of the 2024 Annual General Meeting
- Announcement on Change Registration of Medical Device Production License by Wholly-Owned Subsidiary
- Announcement on Provision of Online Voting Reminder Service for General Meeting
- Announcement on Completion of Industrial and Commercial Change Registration by Wholly-Owned Subsidiary
- Supplementary Announcement on Implementation Results of Repurchasing Shares and Share Changes
Later from Autobio Diagnostics
- Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Henan Jurisdiction
- Announcement on Implementation of Dividend Distribution for 2024
- Announcement on Opening Special Settlement Account for Cash Management Products Using Raised Funds
- Announcement on Cancellation and Termination of Outward Investment by Holding Subsidiary
- Announcement on Result of Shareholding Reduction by Shareholder with Over 5% Shares
Follow Autobio Diagnostics into a list and get an email when it puts out news.
Follow Autobio Diagnostics